Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time

This publication has 43 references indexed in Scilit:

• Levels of absolute survival benefit for systemic therapies of advanced cancer: a call for standards
  European Journal Of Cancer, 2003
• A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials
  Statistics in Medicine, 2002
• Systematic reviews in health care: Assessing the quality of controlled clinical trials
  BMJ, 2001
• Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer
  Seminars in Oncology, 2001
• A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer
  Lung Cancer, 1995
• Use of spending functions for occasional or continuous monitoring of data in clinical trials
  Statistics in Medicine, 1993
• A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
  Cancer Chemotherapy and Pharmacology, 1990
• Platinum‐based combination chemotherapy in advanced non‐small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B
  Medical and Pediatric Oncology, 1990
• Practical problems in interim analyses, with particular regard to estimation
  Controlled Clinical Trials, 1989
• Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study
  European Journal of Cancer and Clinical Oncology, 1984